3+ day, 8+ hour ago   (143+ words) 10 September 2026 | Thursday | News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that its partner, Windward Bio, has reported positive interim results from the Phase 2 portion of the POLARIS-1 clinical trial, which evaluates twice-yearly dosing of SKB378/WIN378 in asthma. The…...

1+ week, 5+ day ago   (344+ words) 01 September 2026 | Tuesday | News Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of global biopharmaceutical innovation, with Chairman and CEO Marc Casper highlighting opportunities to support Chinese drug developers across discovery,…...

1+ mon, 6+ day ago   (282+ words) 07 August 2026 | Friday | News Under China's drug manufacturing license administration regulations, a Class C license permits a company to engage in contract manufacturing on behalf of a Marketing Authorization Holder (MAH). This license is a mandatory legal requirement for entities operating…...

1+ mon, 1+ week ago   (593+ words) BioPharma APAC - Harbour BioMed and Sinopharm Form Strategic Alliance to Accelerate Innovative Biologics 29 July 2026 | Wednesday | News Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, announced…...

1+ mon, 1+ week ago   (1772+ words) 29 July 2026 | Wednesday | Analysis Business development teams across the region keep arriving at the same question, phrased slightly differently each time. What did a comparable asset, at a comparable stage, in a comparable target class, actually fetch? This piece does one…...

1+ mon, 2+ week ago   (94+ words) 29 July 2026 | Wednesday | News Located within AsymBio's Fengxian site, adjacent to the clinical and commercial manufacturing facilities for antibodies and antibody-drug conjugates (ADCs), the building will serve as a dedicated R&D hub. Once operational, it will work in close alignment…...

1+ mon, 2+ week ago   (1410+ words) 27 July 2026 | Monday | Analysis One caveat before the table. This is not the APAC Bioeconomy Index, which is a separate benchmark with its own methodology and a different purpose. This is a siting-decision comparison written for people choosing where to put…...

1+ mon, 2+ week ago   (306+ words) 23 July 2026 | Thursday | Analysis Both stories are told by serious people. Both are partly true. This piece sets out to separate the part of the price that is risk from the part that is reputation, and to be honest about where…...

1+ mon, 2+ week ago   (306+ words) 23 July 2026 | Thursday | Analysis Both stories are told by serious people. Both are partly true. This piece sets out to separate the part of the price that is risk from the part that is reputation, and to be honest about where…...

1+ mon, 3+ week ago   (832+ words) 20 July 2026 | Monday | News Hong Kong is seeking to redefine its place in the global life sciences economy. No longer content to be viewed primarily as a financial gateway into China, the city is building a broader proposition around capital, regulation,…...